Wissenschaftliche Artikel und Publikationen aus dem PEZZ zum Prader-Willi-Syndrom

Lean Body mass  in Boys With Prader-Willi Syndrome Increases Normally During Spontaneous and Induced Puberty, Urs Eiholzer, Kees Noordam, JCEM 2023

Gonadal Hormone Substitution in People with Prader-Labhart-Willi Syndrome: An International Prader-Willi Syndrome Organisation Survey, Hormone Research in Paediatrics,Urs Eiholzer et al; DOI: 10.1159/000518342, 2021

Prader–Willi Syndrome and Hypogonadism: A Review Article, Urs Eiholzer et al; International Journal of Molecular Sciences 2021

Donze, Stephany H., Reply to Commentary on ‘Prevalence of growth hormone (GH) deficiency in previously GH treated young adults with Prader‐ Willi syndrome’  2019

Eiholzer U., Katschnig C., Prader-Willi-Syndrome, Encyclopedia of Endocrine Diseases, 2nd Edition, 2018

The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome. Horm Metab Res. 2013 Jul;45(7):532-6. doi: 10.1055/s-0033-1343449. Epub 2013 Apr 30. Center for Pediatric Endocrinology Zurich, Switzerland.

Eiholzer U, Meinhardt U, Gallo C, Schlumpf M, Rousson V, l'Allemand D. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment. J Pediatr. 2009 Feb;154(2):225-9. Epub 2008 Sep 25.

Eiholzer U, Meinhardt U, Rousson V, Petrovic N, Schlumpf M, l'Allemand D. Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10. Am J Med Genet A. 2008 Apr 1;146(7):873-80.

Eiholzer U, Grieser J, Schlumpf M, l’Allemand D. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome (PWS). Horm Res 2007;68(4):178-184.

Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M. Hypothalamic and Gonadal Components of Hypogonadism in Boys with Prader-Labhart-Willi Syndrome. J Clin Endocrinol Metab 2006;91:892-898.

Schlumpf M, Eiholzer U, Gygax M, Schmid S, van der Sluis I, l’Allemand D. A daily comprehensive muscle training program increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months. Journal of Pediatric Endocrinology and Metabolism 2006;19:65-74.

Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about safety of growth hormone treatment in children with PWS. Hormone Research 2005;63:33-39.

Eiholzer U, l'Allemand D, Schlumpf M, Rousson V, Fusch C. Body composition in children with Prader-Willi syndrome younger than two years and the effect of 30-month growth hormone therapy. J Pediatr 2004;144:753-8.

Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z. Behavioural and emotional disturbances in people with Prader-Willi syndrome. J Intellect Disab Res 2004;48:47-52.

L'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Hormone Research, 2003;59:239-248.

Eiholzer U, Nordmann Y, l'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild K. Improving body composition and physical activity in Prader-Willi Syndrome. Journal of Pediatrics 2003; 142:73-78.

Eiholzer U, Nordmann Y, l'Allemand D. Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment. A case report. Horm Res. 2002;58 Suppl 3:24-26. (Original data)

L'Allemand D, Eiholzer U, Rousson V, Girard J, Blum W, Torresani T et al. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with meas-ures of obesity. Horm Res. 2002;58:215-22.

Steinhausen HC, Von Gontard A, Spohr HL, Hauffa BP, Eiholzer U, Backes M et al. Behavioral phenotypes in four mental retardation syndromes: Fetal alcohol syndrome, Prader-Willi syndrome, fragile X syndrome, and tuberosis sclerosis. Am J Med Genet. 2002;111:381-87.

Nordmann Y, Eiholzer U, l'Allemand D, Mirjanic S, Markwalder C. Sudden death of an infant with Prader-Willi syndrome - not a unique case? Biol Neonate. 2002;82:139-41.

Eiholzer U, L'Allemand D. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after four years of therapy. Horm Res 2000;53:185-192.

L'Allemand D, Eiholzer U, Schlumpf M, Steinert H, Riesen W. Cardiovascular risk factors improve under 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 2000;159:835-842

Eiholzer U, L'Allemand D, van der Sluis I, Steinert H, Ellis K: Body composition abnormalities in children with Prader-Willi syndrome and longterm effects of growth hormone therapy. Horm Res 2000;53:200-206.

Eiholzer U, Malich S, l'Allemand D. Does growth hormone therapy improve motor development in infants with Prader-Willi-syndrome? Eur J Pediatr 2000;159:299. Research letter (original data).

Eiholzer U, Blum WF, Molinari L. Body fat determined by skinfold meas-urements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr 1999;134(2):222-225.Â

Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader, A. Low insulin, IGF-I and IGFBP-3 Levels in Children with Prader-Labhart-Willi Syndrome. Eur J Pediatr 1998;157:890-893.

Eiholzer U, Gisin R, Weinmann C, Kriemler S, Steinert H, Torresani T, Zachmann M, and Prader A. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and in-crases muscle mass and physical performance. Eur J Pediatr 1998;157:368-377.

Non reviewed:

Eiholzer U., Whitman B. A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2004;17:1153-1175

Eiholzer U. Prader-Willi syndrome. In: Martini L (editor in chief): Encyclopedia of Endocrine Diseases, Academic press, 2004

Eiholzer U. Prader-Labhart-Willi Syndrome. Growth Hormone Therapy in Children and Adults. nordiscience 2004:75-82

Eiholzer U. A comprehensive approach to limit weight gain and to normalize body composition in Prader-Willi syndrome. In: Eiholzer U, l'Allemand D, Zipf WB (eds): Prader-Willi syndrome as a model for obesity, Karger Verlag, 2003

Eiholzer U. Treatment strategies to normalize growth, weight and body composition in Prader-Willi syndrome. Current Medical Literature 2003;18(1):1-9

Eiholzer U., Gellatly M., Lee PDK, Ritzén M., Whitman B. A Comprehensive Team Approach to the Management of Prader-Willi Syndrome. IPWSO

Eiholzer U., Schlumpf M., Nordmann Y., l'Allemand D. Early manifestations of Prader-Willi syndrome: influence of growth hormone. J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1441-44

Eiholzer U., Bachmann S., l'Allemand D. Is there a growth hormone deficiency in PWS? Six arguments to support the presence of a hypothalamic GHD in PWS. Horm Res 2000;53:185-192

Eiholzer U., Bachmann S., l'Allemand D. Prader-Labhart-Willi Syndrom and Growth Hormone (invited leading article) Current Medical Literature 2000; 15: 31-35

Eiholzer U., Bachmann S., l'Allemand D. GH treatment as part of comprehensive therapy design for children with PWS (invited leading article) International Growth Monitor 2000;10:3-8

Eiholzer U., Bachmann S., l'Allemand D. Growth hormone deficiency in PWS: a review. The Endocrinologist (USA) 2000;10:50S-56S

Eiholzer U., Weber R, Stutz K, Steinert H. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome. Acta Paediatr 1997;23(Suppl. 4):66-8